4//SEC Filing
Lamond David 4
Accession 0001415889-25-001162
CIK 0001662774other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 7:30 PM ET
Size
5.7 KB
Accession
0001415889-25-001162
Insider Transaction Report
Form 4
Lamond David
Director
Transactions
- Award
Director Stock Option (right to buy)
2025-01-02+47,587→ 47,587 totalExercise: $1.88Exp: 2035-01-02→ Common Stock (47,587 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in equal quarterly installments over a one year-period. The Reporting Person elected to receive the stock options in lieu of the annual director cash retainer for 2025 provided for under the Issuer's Outside Director Compensation Policy.
Documents
Issuer
Quince Therapeutics, Inc.
CIK 0001662774
Entity typeother
Related Parties
1- filerCIK 0001770790
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 7:30 PM ET
- Size
- 5.7 KB